Apyx Medical (APYX) Treasury Shares (2023 - 2025)

Apyx Medical has reported Treasury Shares for 3 years, with the latest figure at $2.1 million in Q4 2025.

• For the quarter ending Q4 2025, Treasury Shares changed 0.08% year-over-year to $2.1 million; the trailing twelve-month figure through Dec 2025 stood at $2.1 million (changed 0.08% YoY), and the FY2025 full-year result was $2.1 million, changed 0.08% from the prior year.
• Treasury Shares for Q4 2025 stood at $2.1 million, roughly flat from $2.1 million in the prior quarter.
• The five-year high for Treasury Shares was $2.1 million in Q4 2025, with the low at $2.1 million in Q4 2023.
• Historically, Treasury Shares has averaged $2.1 million across 3 years, with a median of $2.1 million in 2024.
• Annual changes were most pronounced in 2024 — Treasury Shares grew 3.16% — and 2025, when it gained 0.08%.
• Apyx Medical's Treasury Shares stood at $2.1 million in 2023, then grew by 3.16% to $2.1 million in 2024, then increased by 0.08% to $2.1 million in 2025.
• The last three Treasury Shares figures came in at $2.1 million (Q4 2025), $2.1 million (Q4 2024), and $2.1 million (Q4 2023), per Business Quant data.